Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
TregTherapeutics
AddedFeb 18, 2024
UpdatedJun 18, 2026
TregTherapeutics

TregTherapeutics

TregTherapeutics, a preclinical-stage company, develops a novel vaccine for multiple sclerosis treatment, leveraging Treg cells' power to alter autoimmune disease outcomes.

HQ
Chapel Hill, NC, US
Founded
2018
Overview
Compare
Fundraising
Employees
Website

TregTherapeutics is a preclinical-stage biotechnology company focused on developing innovative treatments for autoimmune diseases, particularly multiple sclerosis. The company's core mission revolves around harnessing the power of T-regulatory cells (Tregs) to modulate immune responses. Their primary product in development is a tolerogenic vaccine aimed at treating and potentially curing multiple sclerosis.

The company's approach draws parallels between the immune system and an orchestra, emphasizing the complex interplay of various components to achieve harmony. TregTherapeutics' work in leveraging Treg cells represents a novel strategy in autoimmune disease treatment, potentially offering new hope for patients with multiple sclerosis and related conditions.

TregTherapeutics - Similar Companies

Tr1x logo

Tr1x

tr1x.bio

Abata Therapeutics logo

Abata Therapeutics

abatatx.com

Tract Therapeutics logo

Tract Therapeutics

Sonoma Biotherapeutics logo

Sonoma Biotherapeutics

TRex Bio logo

TRex Bio

trex.bio

GentiBio logo

GentiBio

gentibio.com

Mozart Therapeutics logo

Mozart Therapeutics

mozart-tx.com

Regor Therapeutics logo

Regor Therapeutics

Tmunity Therapeutics logo

Tmunity Therapeutics

Boston Immune Technologies & Therapeutics logo

Boston Immune Technologies & Therapeutics

TScan Therapeutics logo

TScan Therapeutics

tscan.com

Tactiva Therapeutics logo

Tactiva Therapeutics

TheraJect logo

TheraJect

Tolerion logo

Tolerion

TNeuroPharma logo

TNeuroPharma

tneuropharma.com

TregTherapeutics - Quick Facts

Who are TregTherapeutics' competitors?

Companies similar to TregTherapeutics include Tr1x, Abata Therapeutics, Tract Therapeutics and Sonoma Biotherapeutics.

When was TregTherapeutics founded?

TregTherapeutics was founded in 2018.

Where is TregTherapeutics' headquarters located?

TregTherapeutics' headquarters is located in Chapel Hill, NC, US.

When was TregTherapeutics' last funding round?

TregTherapeutics' most recent funding round was for $250k (USD) in January 2019.

How much has TregTherapeutics raised to-date?

As of Jan 1, 2019, TregTherapeutics has raised a total of $250k (USD).

How many employees does TregTherapeutics have?

TregTherapeutics has 6 employees as of Feb 4, 2024.

TregTherapeutics - Classification

Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Software
Main Product
  • Vaccine
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 15 more industry codes
NAICS
  • 513200Software Publishers
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 510000Information
  • 620000Health Care and Social Assistance
  • 513000Publishing Industries
  • 541700Scientific Research and Development Services
  • 513210Software Publishers
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 7372Prepackaged Software
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research